Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) open the trading on Thursday, with a bit cautious approach as it glided -0.57% to $20.96, before settling in for the price of $21.08 at the close. Taking a more long-term approach, ARWR posted a 52-week range of $17.05-$36.72.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -2.87%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 46.57%. This publicly-traded company’s shares outstanding now amounts to $125.57 million, simultaneously with a float of $116.94 million. The organization now has a market capitalization sitting at $2.64 billion. At the time of writing, stock’s 50-day Moving Average stood at $20.17, while the 200-day Moving Average is $22.48.
Arrowhead Pharmaceuticals Inc (ARWR) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Arrowhead Pharmaceuticals Inc’s current insider ownership accounts for 7.26%, in contrast to 77.05% institutional ownership. According to the most recent insider trade that took place on Jan 23 ’25, this organization’s Director sold 959 shares at the rate of 21.00, making the entire transaction reach 20,139 in total value, affecting insider ownership by 35,781.
Arrowhead Pharmaceuticals Inc (ARWR) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.02 per share during the current fiscal year.
Arrowhead Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 46.57% and is forecasted to reach -3.74 in the upcoming year.
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Trading Performance Indicators
Let’s observe the current performance indicators for Arrowhead Pharmaceuticals Inc (ARWR). It’s Quick Ratio in the last reported quarter now stands at 6.09. The Stock has managed to achieve an average true range (ATR) of 1.08. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1057.21.
In the same vein, ARWR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.15, a figure that is expected to reach -0.11 in the next quarter, and analysts are predicting that it will be -3.74 at the market close of one year from today.
Technical Analysis of Arrowhead Pharmaceuticals Inc (ARWR)
[Arrowhead Pharmaceuticals Inc, ARWR] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 76.27% While, its Average True Range was 1.06.
Raw Stochastic average of Arrowhead Pharmaceuticals Inc (ARWR) in the period of the previous 100 days is set at 38.00%, which indicates a major fall in contrast to 79.39% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 51.63% that was lower than 66.11% volatility it exhibited in the past 100-days period.
